NM_015909.4:c.1749G>A
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_015909.4(NBAS):c.1749G>A(p.Trp583*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,461,742 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_015909.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- infantile liver failure syndrome 2Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
- short stature-optic atrophy-Pelger-Huët anomaly syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Illumina, Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_015909.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NBAS | NM_015909.4 | MANE Select | c.1749G>A | p.Trp583* | stop_gained | Exon 17 of 52 | NP_056993.2 | ||
| NBAS | NR_052013.3 | n.1779G>A | non_coding_transcript_exon | Exon 17 of 51 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NBAS | ENST00000281513.10 | TSL:1 MANE Select | c.1749G>A | p.Trp583* | stop_gained | Exon 17 of 52 | ENSP00000281513.5 | ||
| NBAS | ENST00000700066.1 | c.1266G>A | p.Trp422* | stop_gained | Exon 15 of 22 | ENSP00000514780.1 | |||
| NBAS | ENST00000700069.1 | c.1620G>A | p.Trp540* | stop_gained | Exon 16 of 17 | ENSP00000514781.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.0000159 AC: 4AN: 251226 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461742Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 727168 show subpopulations
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Infantile liver failure syndrome 2 Pathogenic:1
not provided Pathogenic:1
This sequence change creates a premature translational stop signal (p.Trp583*) in the NBAS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NBAS are known to be pathogenic (PMID: 26073778, 26541327, 27789416, 28031453). This variant is present in population databases (rs770446752, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with NBAS-related conditions (PMID: 28576691). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 424842). For these reasons, this variant has been classified as Pathogenic.
NBAS-related disorder Pathogenic:1
The NBAS c.1749G>A variant is predicted to result in premature protein termination (p.Trp583*). This variant has been reported in the compound heterozygous state in two siblings with recurrent elevated liver transaminases and acute liver failure (Regateiro et al 2017. PubMed ID: 28576691). This variant is reported in 0.0058% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-15608634-C-T). Nonsense variants in NBAS are expected to be pathogenic. This variant is interpreted as pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at